Dr. Sangrigoli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
599 W State St
Suite 200
Doylestown, PA 18901Phone+1 267-893-6800Fax+1 267-893-6820
Education & Training
- Temple University HospitalFellowship, Cardiovascular Disease, 1996 - 1999
- Temple University HospitalResidency, Internal Medicine, 1993 - 1996
- Lewis Katz School of Medicine at Temple UniversityClass of 1993
Certifications & Licensure
- PA State Medical License 1994 - 2024
- NJ State Medical License 1999 - 2003
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolley, 2019
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Ranolazine Implantable Cardioverter-Defibrillator Trial Start of enrollment: 2011 Sep 01
- A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial Start of enrollment: 2021 Apr 20
Publications & Presentations
PubMed
- 49 citationsComparison of pulmonary uptake with transient cavity dilation after exercise thallium-201 perfusion imagingChristopher L. Hansen, Renee Sangrigoli, Emeke Nkadi, Matt Kramer
Journal of the American College of Cardiology. 1999-04-01 - 2 citationsOn myocardial perfusion, metabolism, and viabilityChristopher L. Hansen, Amitabh Rastogi, Renee Sangrigoli
Journal of Nuclear Cardiology. 1998-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: